- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 01: N-(4-{2-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}-3-fluorophenyl)ethanesulfonamide
01.1: 21 residues within 4Å:- Chain A: G.201, V.202, S.203, R.215, T.217, G.218, T.219
- Chain B: V.258, Y.262, Y.266, L.271, V.276, A.277, N.307, G.310, S.311, R.314, A.345, L.346, W.349
- Ligands: ANP.3
9 PLIP interactions:6 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:V.258, B:L.271, B:A.277, B:A.345
- Hydrogen bonds: B:R.314, A:R.215, A:R.215
- pi-Stacking: B:W.349
- pi-Cation interactions: A:R.215
01.7: 21 residues within 4Å:- Chain A: V.258, Y.262, Y.266, L.271, V.276, A.277, N.307, G.310, S.311, R.314, A.345, L.346, W.349
- Chain B: G.201, V.202, S.203, R.215, T.217, G.218, T.219
- Ligands: ANP.9
9 PLIP interactions:6 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:V.258, A:L.271, A:A.277, A:A.345
- Hydrogen bonds: A:R.314, B:R.215, B:R.215
- pi-Stacking: A:W.349
- pi-Cation interactions: B:R.215
- 2 x ACY: ACETIC ACID(Non-functional Binders)
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
ANP.3: 21 residues within 4Å:- Chain A: G.27, G.28, T.29, L.30, K.32, G.199, S.200, G.201, G.223, G.224, L.227, F.239, E.240, G.329, N.330, F.331, R.333
- Chain B: I.261
- Ligands: 01.1, MG.4, EDO.5
25 PLIP interactions:25 interactions with chain A- Hydrogen bonds: A:G.28, A:T.29, A:T.29, A:L.30, A:K.32, A:R.94, A:G.199, A:S.200, A:S.200, A:G.201, A:G.223, A:E.240, A:N.330, A:N.330, A:F.331, A:R.333
- Water bridges: A:E.146, A:E.146, A:E.146, A:N.197, A:N.197, A:G.199, A:G.199
- Salt bridges: A:K.32
- pi-Stacking: A:F.239
ANP.9: 21 residues within 4Å:- Chain A: I.261
- Chain B: G.27, G.28, T.29, L.30, K.32, G.199, S.200, G.201, G.223, G.224, L.227, F.239, E.240, G.329, N.330, F.331, R.333
- Ligands: 01.7, MG.10, EDO.11
22 PLIP interactions:22 interactions with chain B- Hydrogen bonds: B:G.28, B:T.29, B:L.30, B:K.32, B:R.94, B:G.199, B:S.200, B:S.200, B:G.201, B:G.223, B:E.240, B:N.330, B:N.330, B:F.331, B:R.333
- Water bridges: B:T.29, B:N.197, B:N.197, B:G.199, B:G.199
- Salt bridges: B:K.32
- pi-Stacking: B:F.239
- 2 x MG: MAGNESIUM ION(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 5 residues within 4Å:- Chain A: L.30, T.69, R.94, F.95
- Ligands: ANP.3
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.94
EDO.6: 6 residues within 4Å:- Chain A: I.284, R.289
- Chain B: L.227, S.231, C.236, E.237
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.289, A:R.289
- Water bridges: A:K.286
EDO.11: 5 residues within 4Å:- Chain B: L.30, T.69, R.94, F.95
- Ligands: ANP.9
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.94
EDO.12: 6 residues within 4Å:- Chain A: L.227, S.231, C.236, E.237
- Chain B: I.284, R.289
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.289, B:R.289
- Water bridges: B:K.286
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yun, M. et al., 2-(4-aminophenyl)acetamide derivatives as Pantothenate Kinase Inhibitors. To Be Published
- Release Date
- 2025-08-13
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 01: N-(4-{2-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}-3-fluorophenyl)ethanesulfonamide
- 2 x ACY: ACETIC ACID(Non-functional Binders)
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yun, M. et al., 2-(4-aminophenyl)acetamide derivatives as Pantothenate Kinase Inhibitors. To Be Published
- Release Date
- 2025-08-13
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A